265 related articles for article (PubMed ID: 36584935)
1. CD8
Wang Q; Qin Y; Li B
Cancer Lett; 2023 Apr; 559():216043. PubMed ID: 36584935
[TBL] [Abstract][Full Text] [Related]
2. CD8
Huang Y; Jia A; Wang Y; Liu G
Immunology; 2023 Jan; 168(1):30-48. PubMed ID: 36190809
[TBL] [Abstract][Full Text] [Related]
3. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
Front Immunol; 2020; 11():622509. PubMed ID: 33633741
[TBL] [Abstract][Full Text] [Related]
4. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
Cheng H; Ma K; Zhang L; Li G
Cancer Lett; 2021 May; 506():55-66. PubMed ID: 33662493
[TBL] [Abstract][Full Text] [Related]
5. CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy.
Ando S; Araki K
Int Immunol; 2022 Oct; 34(11):571-577. PubMed ID: 35901837
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
[TBL] [Abstract][Full Text] [Related]
7. Reinvigorating exhausted CD8
Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
[TBL] [Abstract][Full Text] [Related]
8. Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.
Zhang L; Zhang B; Li L; Ye Y; Wu Y; Yuan Q; Xu W; Wen X; Guo X; Nian S
J Cancer Res Clin Oncol; 2023 May; 149(5):2243-2258. PubMed ID: 36107246
[TBL] [Abstract][Full Text] [Related]
9. TOX promotes the exhaustion of antitumor CD8
Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion.
Li F; Wang Y; Chen D; Du Y
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338674
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Cbl-b inhibits CD8
Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.
Fu Y; Wang J; Liu C; Liao K; Gao X; Tang R; Fan B; Hong Y; Xiao N; Xiao C; Liu WH
Cell Mol Immunol; 2023 Oct; 20(10):1127-1139. PubMed ID: 37553428
[TBL] [Abstract][Full Text] [Related]
13. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
[TBL] [Abstract][Full Text] [Related]
14. Novel T cell exhaustion gene signature to predict prognosis and immunotherapy response in thyroid carcinoma from integrated RNA-sequencing analysis.
Li Y; Wang Z; Lu F; Miao Y; Feng Q; Zhu W; Kang Q; Chen Y; Zhang Q
Sci Rep; 2024 Apr; 14(1):8375. PubMed ID: 38600248
[TBL] [Abstract][Full Text] [Related]
15. The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer.
Zhang J; Lei F; Tan H
Front Immunol; 2023; 14():1166128. PubMed ID: 37275913
[TBL] [Abstract][Full Text] [Related]
16. Strategies to reinvigorate exhausted CD8
Guan Q; Han M; Guo Q; Yan F; Wang M; Ning Q; Xi D
Front Immunol; 2023; 14():1204363. PubMed ID: 37398660
[TBL] [Abstract][Full Text] [Related]
17. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY
Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672
[TBL] [Abstract][Full Text] [Related]
18. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
19. CD8
Kurachi M
Semin Immunopathol; 2019 May; 41(3):327-337. PubMed ID: 30989321
[TBL] [Abstract][Full Text] [Related]
20. Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy.
Trefny MP; Kirchhammer N; Auf der Maur P; Natoli M; Schmid D; Germann M; Fernandez Rodriguez L; Herzig P; Lötscher J; Akrami M; Stinchcombe JC; Stanczak MA; Zingg A; Buchi M; Roux J; Marone R; Don L; Lardinois D; Wiese M; Jeker LT; Bentires-Alj M; Rossy J; Thommen DS; Griffiths GM; Läubli H; Hess C; Zippelius A
Nat Commun; 2023 Feb; 14(1):86. PubMed ID: 36732507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
